DigestRedComo funciona
Red
/
Empresas
De
No verificado

Definium Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosPsiquiatríaSalud

37 Comunicados de prensa

Ver todos los comunicados de prensa
12/08/2026
Web y redes sociales
Industria
Psiquiatría
Ciencia
Higiene alimentaria
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder
Fuente
Definium Therapeutics, Inc.
Editor
Business Wire
1.00
0
06/08/2026
Web y redes sociales
Telefonía
Mercado de valores
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
Fuente
Definium Therapeutics, Inc.
Editor
Business Wire
1.00
0
03/08/2026
Mercado de valores
Finanzas
Biotecnología
Farmacéutica
Salud
Definium Therapeutics Announces New Employee Inducement Grants
Fuente
Definium Therapeutics, Inc.
Editor
Business Wire
1.00
0
30/07/2026
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Medicina alternativa
Salud
Ciencia
Farmacéutica
Biotecnología
Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
Fuente
Definium Therapeutics, Inc.
Editor
Business Wire
1.00
0
20/07/2026
Mercado laboral
Finanzas
Medicina alternativa
Psiquiatría
Salud
Farmacéutica
Biotecnología
Definium Therapeutics Announces New Employee Inducement Grants
Fuente
Definium Therapeutics, Inc.
Editor
Business Wire
1.00
0
16/07/2026
Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology
Fuente
Definium Therapeutics, Inc.
Editor
Business Wire
1.00
0
14/07/2026
Ciencia
Farmacéutica
Medicina alternativa
Sanidad
Salud
Psiquiatría
Análisis de Mercados
Industria
New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Care Among Patients with Generalized Anxiety Disorder (GAD)
Fuente
Definium Therapeutics, Inc.
Editor
Business Wire
1.00
0
06/07/2026
Mercado de valores
Psiquiatría
Ciencia
Biotecnología
Medicina alternativa
Salud
Farmacéutica
Definium Therapeutics Announces New Employee Inducement Grants
Fuente
Definium Therapeutics, Inc.
Editor
Business Wire
1.00
0
25/06/2026
Finanzas
Ciencia
Biotecnología
Farmacéutica
Medicina alternativa
Salud
Psiquiatría
Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Fuente
Definium Therapeutics, Inc.
Editor
Business Wire
1.00
0
24/06/2026
Finanzas
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering
Fuente
Definium Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0